Article
Clioquinol improves catalytic activity of PHGDH and shows antiseizure efficacy in patients
2024-10-01
Abstract excerpt
Drug-resistant epilepsy (DRE) affects over 25 million people worldwide and is associated with neuroinflammation. We identified haloquinolines from a drug repurposing library as potent activators of phosphoglycerate dehydrogenase (PHGDH) enzyme, which converts 3-phosphoglycerate to generate serine and the neurotransmitter glycine, and steers anti-inflammatory responses. The most promising haloquinoline clioquinol c...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a5e33ef8-63c7-5866-a3d3-ef4134348ded
- DOI
- 10.1101/2024.09.28.24314470
